Executive Summary

Japan has been implementing pro-generic policies to increase the uptake of generics. The price of a new generic entering the market is determined based on the price(s) of the available drugs (branded and/or other generic). Exceptional price reductions are applied for branded drugs (2-1.5%) that are deemed not to have been adequately replaced by generic drugs.